4.7 Article

CDK6 Levels Regulate Quiescence Exit in Human Hematopoietic Stem Cells

期刊

CELL STEM CELL
卷 16, 期 3, 页码 302-313

出版社

CELL PRESS
DOI: 10.1016/j.stem.2015.01.017

关键词

-

资金

  1. Swiss National Science Foundation
  2. Roche
  3. Fondation Suisse pour les Bourses en Medecine et Biologie
  4. Swedish Research Council
  5. Canadian Institutes of Health Research (CIHR)
  6. Aplastic Anemia and Myelodysplasia Association of Canada
  7. CIHR
  8. Canadian Cancer Society
  9. Terry Fox Foundation
  10. Genome Canada through Ontario Genomics Institute
  11. Ontario Institute for Cancer Research
  12. province of Ontario, a Canada Research Chair
  13. Princess Margaret Hospital foundation
  14. Ontario Ministry of Health and Long Term Care (OMOHLTC)
  15. Wellcome Trust
  16. MRC

向作者/读者索取更多资源

Regulated blood production is achieved through the hierarchical organization of dormant hematopoietic stem cell (HSC) subsets that differ in self-renewal potential and division frequency, with long-term (LT)-HSCs dividing the least. The molecular mechanisms underlying this variability in HSC division kinetics are unknown. We report here that quiescence exit kinetics are differentially regulated within human HSC subsets through the expression level of CDK6. LT-HSCs lack CDK6 protein. Short-term (ST)-HSCs are also quiescent but contain high CDK6 protein levels that permit rapid cell cycle entry upon mitogenic stimulation. Enforced CDK6 expression in LT-HSCs shortens quiescence exit and confers competitive advantage without impacting function. Computational modeling suggests that this independent control of quiescence exit kinetics inherently limits LT-HSC divisions and preserves the HSC pool to ensure lifelong hematopoiesis. Thus, differential expression of CDK6 underlies heterogeneity in stem cell quiescence states that functionally regulates this highly regenerative system.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据